Anti-IA2 is present in the majority of individuals with new onset Type 1 diabetes and, in the pre-diabetic phase of the disease, its appearance seems to be correlated with the rapid progression to overt Type 1 diabetes [24,29,30]. This evidence concerns the gene PTPRN and type 1 diabetes mellitus.